The U.S. Food and Drug Administration said Monday that it will curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant.This article was originally published […]
(HealthDay)—For patients with gout and chronic kidney disease (CKD), no associations with increased mortality were seen for allopurinol initiation, achieving target serum urate (SU) levels, or allopurinol dose escalation, according to a study published online […]
A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that, combinatorial pharmacogenetics-guided treatment did not demonstrate improved outcomes for adolescents with depression compared to those […]
Recently published in JAMA Network Open, University of Minnesota Medical School researchers found that during a four-year period, patient out-of-pocket spending increased for hepatitis B medication, entecavir.This article was originally published on MedicalXpress.com
Cannabidiol, a compound derived from marijuana, appears to show promise in blocking replication of the COVID-19 virus and preventing its spread, lab and animal studies show.This article was originally published on MedicalXpress.com
(HealthDay)—Schools should stock the opioid overdose antidote naloxone and train staff and students how to respond to an overdose, experts say after the apparent fentanyl overdose death of seventh grader at a school in Hartford, […]
The U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant.This article was originally published on MedicalXpress.com
(HealthDay)—STRIDE (Single tremelimumab Regular Interval durvalumab) is proposed as first-line therapy for unresectable hepatocellular carcinoma (uHCC), according to a study presented at the annual American Society of Clinical Oncology Gastrointestinal Cancers Symposium, held from Jan. […]
University of Queensland researchers have unlocked a way of fighting Listeria infections, which can cause severe illness in pregnant women and people with compromised immune systems.This article was originally published on MedicalXpress.com
(HealthDay)—Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous liraglutide, according to a study published in […]
© 2022 SimplyWell.ca